
Top News
October 12, 2022
Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers
March 22, 2022
Vita Therapeutics Bolsters Leadership to Advance Multiple Technology Platforms
July 23, 2021
Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment